Cue Biopharma, Inc. Form 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Cue Biopharma, Inc. on May 25, 2018. The report addresses a change in the location of the company's 2018 Annual Meeting of Stockholders, originally scheduled for June 12, 2018.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current report regarding a corporate event and does not contain financial statements or performance metrics.
Material Changes
The material change reported is the relocation of the 2018 Annual Meeting of Stockholders. The meeting date, time, and record date remain unchanged. The new venue is:
- The Warwick Melrose Hotel, Oak Lawn Terrace Conference Room
- 3015 Oak Lawn Ave, Dallas, Texas 75219
- Time: 9:00 a.m., local time
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on operations, risks, contingencies, or unusual items. The document strictly serves to notify stockholders of the venue change pursuant to Regulation FD.
Key Facts for Investors
- The 2018 Annual Meeting date remains Tuesday, June 12, 2018.
- The meeting location has changed to Dallas, Texas.
- A formal Notice to Stockholders regarding this change is included as Exhibit 99.1.
- The company is designated as an emerging growth company.